Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

Thorax logoLink to Thorax
. 2002 Aug;57(8):736–741. doi: 10.1136/thorax.57.8.736

Chronic obstructive pulmonary disease • 1: Susceptibility factors for COPD the genotype–environment interaction

A Sandford 1, E Silverman 1
PMCID: PMC1746410  PMID: 12149538

Full Text

The Full Text of this article is available as a PDF (156.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albert P. S., Ratnasinghe D., Tangrea J., Wacholder S. Limitations of the case-only design for identifying gene-environment interactions. Am J Epidemiol. 2001 Oct 15;154(8):687–693. doi: 10.1093/aje/154.8.687. [DOI] [PubMed] [Google Scholar]
  2. Alvarez-Granda L., Cabero-Perez M. J., Bustamante-Ruiz A., Gonzalez-Lamuño D., Delgado-Rodriguez M., García-Fuentes M. PI SZ phenotype in chronic obstructive pulmonary disease. Thorax. 1997 Jul;52(7):659–661. doi: 10.1136/thx.52.7.659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baranova H., Perriot J., Albuisson E., Ivaschenko T., Baranov V. S., Hemery B., Mouraire P., Riol N., Malet P. Peculiarities of the GSTM1 0/0 genotype in French heavy smokers with various types of chronic bronchitis. Hum Genet. 1997 Jun;99(6):822–826. doi: 10.1007/s004390050455. [DOI] [PubMed] [Google Scholar]
  4. Bartmann K., Fooke-Achterrath M., Koch G., Nagy I., Schütz I., Weis E., Zierski M. Heterozygosity in the Pi-system as a pathogenetic cofactor in chronic obstructive pulmonary disease (COPD). Eur J Respir Dis. 1985 Apr;66(4):284–296. [PubMed] [Google Scholar]
  5. Beaty T. H., Menkes H. A., Cohen B. H., Newill C. A. Risk factors associated with longitudinal change in pulmonary function. Am Rev Respir Dis. 1984 May;129(5):660–667. doi: 10.1164/arrd.1984.129.5.660. [DOI] [PubMed] [Google Scholar]
  6. Benetazzo M. G., Gilè L. S., Bombieri C., Malerba G., Massobrio M., Pignatti P. F., Luisetti M. alpha 1-antitrypsin TAQ I polymorphism and alpha 1-antichymotrypsin mutations in patients with obstructive pulmonary disease. Respir Med. 1999 Sep;93(9):648–654. doi: 10.1016/s0954-6111(99)90105-1. [DOI] [PubMed] [Google Scholar]
  7. Björkander J., Bake B., Oxelius V. A., Hanson L. A. Impaired lung function in patients with IgA deficiency and low levels of IgG2 or IgG3. N Engl J Med. 1985 Sep 19;313(12):720–724. doi: 10.1056/NEJM198509193131203. [DOI] [PubMed] [Google Scholar]
  8. Black L. F., Kueppers F. alpha1-Antitrypsin deficiency in nonsmokers. Am Rev Respir Dis. 1978 Mar;117(3):421–428. doi: 10.1164/arrd.1978.117.3.421. [DOI] [PubMed] [Google Scholar]
  9. Bombieri C., Benetazzo M., Saccomani A., Belpinati F., Gilè L. S., Luisetti M., Pignatti P. F. Complete mutational screening of the CFTR gene in 120 patients with pulmonary disease. Hum Genet. 1998 Dec;103(6):718–722. doi: 10.1007/s004390050897. [DOI] [PubMed] [Google Scholar]
  10. Bouma G., Crusius J. B., Oudkerk Pool M., Kolkman J. J., von Blomberg B. M., Kostense P. J., Giphart M. J., Schreuder G. M., Meuwissen S. G., Peña A. S. Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol. 1996 Apr;43(4):456–463. doi: 10.1046/j.1365-3083.1996.d01-65.x. [DOI] [PubMed] [Google Scholar]
  11. Cantlay A. M., Lamb D., Gillooly M., Norrman J., Morrison D., Smith C. A., Harrison D. J. Association between the CYP1A1 gene polymorphism and susceptibility to emphysema and lung cancer. Clin Mol Pathol. 1995 Aug;48(4):M210–M214. doi: 10.1136/mp.48.4.m210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Cantlay A. M., Smith C. A., Wallace W. A., Yap P. L., Lamb D., Harrison D. J. Heterogeneous expression and polymorphic genotype of glutathione S-transferases in human lung. Thorax. 1994 Oct;49(10):1010–1014. doi: 10.1136/thx.49.10.1010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Celedon J. C., Speizer F. E., Drazen J. M., Weiss S. T., Campbell E. J., Carey V. J., Reilly J. J., Ginns L., Silverman E. K. Bronchodilator responsiveness and serum total IgE levels in families of probands with severe early-onset COPD. Eur Respir J. 1999 Nov;14(5):1009–1014. doi: 10.1183/09031936.99.14510099. [DOI] [PubMed] [Google Scholar]
  14. Chen Y., Horne S. L., Rennie D. C., Dosman J. A. Segregation analysis of two lung function indices in a random sample of young families: the Humboldt Family Study. Genet Epidemiol. 1996;13(1):35–47. doi: 10.1002/(SICI)1098-2272(1996)13:1<35::AID-GEPI4>3.0.CO;2-5. [DOI] [PubMed] [Google Scholar]
  15. Choi A. M., Alam J. Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am J Respir Cell Mol Biol. 1996 Jul;15(1):9–19. doi: 10.1165/ajrcmb.15.1.8679227. [DOI] [PubMed] [Google Scholar]
  16. Cohen B. H., Ball W. C., Jr, Brashears S., Diamond E. L., Kreiss P., Levy D. A., Menkes H. A., Permutt S., Tockman M. S. Risk factors in chronic obstructive pulmonary disease (COPD). Am J Epidemiol. 1977 Mar;105(3):223–232. doi: 10.1093/oxfordjournals.aje.a112378. [DOI] [PubMed] [Google Scholar]
  17. Cohen B. H., Bias W. B., Chase G. A., Diamond E. L., Graves C. G., Levy D. A., Menkes H., Meyer M. B., Permutt S., Tockman M. S. Is ABH nonsecretor status a risk factor for obstructive lung disease? Am J Epidemiol. 1980 Mar;111(3):285–291. doi: 10.1093/oxfordjournals.aje.a112898. [DOI] [PubMed] [Google Scholar]
  18. Cohen B. H. Chronic obstructive pulmonary disease: a challenge in genetic epidemiology. Am J Epidemiol. 1980 Aug;112(2):274–288. doi: 10.1093/oxfordjournals.aje.a112994. [DOI] [PubMed] [Google Scholar]
  19. Cohen B. H., Diamond E. L., Graves C. G., Kreiss P., Levy D. A., Menkes H. A., Permutt S., Quaskey S., Tockman M. S. A common familial component in lung cancer and chronic obstructive pulmonary disease. Lancet. 1977 Sep 10;2(8037):523–526. doi: 10.1016/s0140-6736(77)90663-8. [DOI] [PubMed] [Google Scholar]
  20. Cuppens H., Lin W., Jaspers M., Costes B., Teng H., Vankeerberghen A., Jorissen M., Droogmans G., Reynaert I., Goossens M. Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. J Clin Invest. 1998 Jan 15;101(2):487–496. doi: 10.1172/JCI639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Dahl M., Nordestgaard B. G., Lange P., Vestbo J., Tybjaerg-Hansen A. Molecular diagnosis of intermediate and severe alpha(1)-antitrypsin deficiency: MZ individuals with chronic obstructive pulmonary disease may have lower lung function than MM individuals. Clin Chem. 2001 Jan;47(1):56–62. [PubMed] [Google Scholar]
  22. Gauderman W. J., Siegmund K. D. Gene-environment interaction and affected sib pair linkage analysis. Hum Hered. 2001;52(1):34–46. doi: 10.1159/000053352. [DOI] [PubMed] [Google Scholar]
  23. Givelber R. J., Couropmitree N. N., Gottlieb D. J., Evans J. C., Levy D., Myers R. H., O'Connor G. T. Segregation analysis of pulmonary function among families in the Framingham Study. Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1445–1451. doi: 10.1164/ajrccm.157.5.9704021. [DOI] [PubMed] [Google Scholar]
  24. Harrison D. J., Cantlay A. M., Rae F., Lamb D., Smith C. A. Frequency of glutathione S-transferase M1 deletion in smokers with emphysema and lung cancer. Hum Exp Toxicol. 1997 Jul;16(7):356–360. doi: 10.1177/096032719701600703. [DOI] [PubMed] [Google Scholar]
  25. Hassett C., Aicher L., Sidhu J. S., Omiecinski C. J. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet. 1994 Mar;3(3):421–428. doi: 10.1093/hmg/3.3.421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Higgins M., Keller J. Familial occurrence of chronic respiratory disease and familial resemblance in ventilatory capacity. J Chronic Dis. 1975 Apr;28(4):239–251. doi: 10.1016/0021-9681(75)90053-3. [DOI] [PubMed] [Google Scholar]
  27. Higham M. A., Pride N. B., Alikhan A., Morrell N. W. Tumour necrosis factor-alpha gene promoter polymorphism in chronic obstructive pulmonary disease. Eur Respir J. 2000 Feb;15(2):281–284. doi: 10.1034/j.1399-3003.2000.15b10.x. [DOI] [PubMed] [Google Scholar]
  28. Horne S. L., Cockcroft D. W., Dosman J. A. Possible protective effect against chronic obstructive airways disease by the GC2 allele. Hum Hered. 1990;40(3):173–176. doi: 10.1159/000153926. [DOI] [PubMed] [Google Scholar]
  29. Huang S. L., Su C. H., Chang S. C. Tumor necrosis factor-alpha gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med. 1997 Nov;156(5):1436–1439. doi: 10.1164/ajrccm.156.5.9609138. [DOI] [PubMed] [Google Scholar]
  30. Ishii T., Matsuse T., Teramoto S., Matsui H., Hosoi T., Fukuchi Y., Ouchi Y. Association between alpha-1-antichymotrypsin polymorphism and susceptibility to chronic obstructive pulmonary disease. Eur J Clin Invest. 2000 Jun;30(6):543–548. doi: 10.1046/j.1365-2362.2000.00655.x. [DOI] [PubMed] [Google Scholar]
  31. Ishii T., Matsuse T., Teramoto S., Matsui H., Miyao M., Hosoi T., Takahashi H., Fukuchi Y., Ouchi Y. Glutathione S-transferase P1 (GSTP1) polymorphism in patients with chronic obstructive pulmonary disease. Thorax. 1999 Aug;54(8):693–696. doi: 10.1136/thx.54.8.693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Ishii T., Matsuse T., Teramoto S., Matsui H., Miyao M., Hosoi T., Takahashi H., Fukuchi Y., Ouchi Y. Neither IL-1beta, IL-1 receptor antagonist, nor TNF-alpha polymorphisms are associated with susceptibility to COPD. Respir Med. 2000 Sep;94(9):847–851. doi: 10.1053/rmed.2000.0808. [DOI] [PubMed] [Google Scholar]
  33. Janus E. D., Phillips N. T., Carrell R. W. Smoking, lung function, and alpha 1-antitrypsin deficiency. Lancet. 1985 Jan 19;1(8421):152–154. doi: 10.1016/s0140-6736(85)91916-6. [DOI] [PubMed] [Google Scholar]
  34. Kalsheker N. A., Watkins G. L., Hill S., Morgan K., Stockley R. A., Fick R. B. Independent mutations in the flanking sequence of the alpha-1-antitrypsin gene are associated with chronic obstructive airways disease. Dis Markers. 1990 May-Jun;8(3):151–157. [PubMed] [Google Scholar]
  35. Kauffmann F., Frette C., Pham Q. T., Nafissi S., Bertrand J. P., Oriol R. Associations of blood group-related antigens to FEV1, wheezing, and asthma. Am J Respir Crit Care Med. 1996 Jan;153(1):76–82. doi: 10.1164/ajrccm.153.1.8542166. [DOI] [PubMed] [Google Scholar]
  36. Kauffmann F., Kleisbauer J. P., Cambon-De-Mouzon A., Mercier P., Constans J., Blanc M., Rouch Y., Feingold N. Genetic markers in chronic air-flow limitation. A genetic epidemiologic study. Am Rev Respir Dis. 1983 Mar;127(3):263–269. doi: 10.1164/arrd.1983.127.3.263. [DOI] [PubMed] [Google Scholar]
  37. Keicho N., Tokunaga K., Nakata K., Taguchi Y., Azuma A., Bannai M., Emi M., Ohishi N., Yazaki Y., Kudoh S. Contribution of HLA genes to genetic predisposition in diffuse panbronchiolitis. Am J Respir Crit Care Med. 1998 Sep;158(3):846–850. doi: 10.1164/ajrccm.158.3.9712125. [DOI] [PubMed] [Google Scholar]
  38. Khoury M. J., Flanders W. D. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls! Am J Epidemiol. 1996 Aug 1;144(3):207–213. doi: 10.1093/oxfordjournals.aje.a008915. [DOI] [PubMed] [Google Scholar]
  39. Kitteringham N. R., Davis C., Howard N., Pirmohamed M., Park B. K. Interindividual and interspecies variation in hepatic microsomal epoxide hydrolase activity: studies with cis-stilbene oxide, carbamazepine 10, 11-epoxide and naphthalene. J Pharmacol Exp Ther. 1996 Sep;278(3):1018–1027. [PubMed] [Google Scholar]
  40. Krzyzanowski M., Jedrychowski W., Wysocki M. Factors associated with the change in ventilatory function and the development of chronic obstructive pulmonary disease in a 13-year follow-up of the Cracow Study. Risk of chronic obstructive pulmonary disease. Am Rev Respir Dis. 1986 Nov;134(5):1011–1019. doi: 10.1164/arrd.1986.134.5.1011. [DOI] [PubMed] [Google Scholar]
  41. Kueppers F., Miller R. D., Gordon H., Hepper N. G., Offord K. Familial prevalence of chronic obstructive pulmonary disease in a matched pair study. Am J Med. 1977 Sep;63(3):336–342. doi: 10.1016/0002-9343(77)90270-4. [DOI] [PubMed] [Google Scholar]
  42. Larson R. K., Barman M. L., Kueppers F., Fudenberg H. H. Genetic and environmental determinants of chronic obstructive pulmonary disease. Ann Intern Med. 1970 May;72(5):627–632. doi: 10.7326/0003-4819-72-5-627. [DOI] [PubMed] [Google Scholar]
  43. Larsson C. Natural history and life expectancy in severe alpha1-antitrypsin deficiency, Pi Z. Acta Med Scand. 1978;204(5):345–351. doi: 10.1111/j.0954-6820.1978.tb08452.x. [DOI] [PubMed] [Google Scholar]
  44. Mahadeva R., Westerbeek R. C., Perry D. J., Lovegrove J. U., Whitehouse D. B., Carroll N. R., Ross-Russell R. I., Webb A. K., Bilton D., Lomas D. A. Alpha1-antitrypsin deficiency alleles and the Taq-I G-->A allele in cystic fibrosis lung disease. Eur Respir J. 1998 Apr;11(4):873–879. doi: 10.1183/09031936.98.11040873. [DOI] [PubMed] [Google Scholar]
  45. Mayer A. S., Stoller J. K., Bucher Bartelson B., James Ruttenber A., Sandhaus R. A., Newman L. S. Occupational exposure risks in individuals with PI*Z alpha(1)-antitrypsin deficiency. Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):553–558. doi: 10.1164/ajrccm.162.2.9907117. [DOI] [PubMed] [Google Scholar]
  46. Morgan K., Scobie G., Kalsheker N. A. Point mutation in a 3' flanking sequence of the alpha-1-antitrypsin gene associated with chronic respiratory disease occurs in a regulatory sequence. Hum Mol Genet. 1993 Mar;2(3):253–257. doi: 10.1093/hmg/2.3.253. [DOI] [PubMed] [Google Scholar]
  47. Morgan K., Scobie G., Marsters P., Kalsheker N. A. Mutation in an alpha1-antitrypsin enhancer results in an interleukin-6 deficient acute-phase response due to loss of cooperativity between transcription factors. Biochim Biophys Acta. 1997 Nov 28;1362(1):67–76. doi: 10.1016/s0925-4439(97)00064-1. [DOI] [PubMed] [Google Scholar]
  48. Naylor L. H., Clark E. M. d(TG)n.d(CA)n sequences upstream of the rat prolactin gene form Z-DNA and inhibit gene transcription. Nucleic Acids Res. 1990 Mar 25;18(6):1595–1601. doi: 10.1093/nar/18.6.1595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. O'Keeffe S., Gzel A., Drury R., Cullina M., Greally J., Finnegan P. Immunoglobulin G subclasses and spirometry in patients with chronic obstructive pulmonary disease. Eur Respir J. 1991 Sep;4(8):932–936. [PubMed] [Google Scholar]
  50. Otterbein L. E., Lee P. J., Chin B. Y., Petrache I., Camhi S. L., Alam J., Choi A. M. Protective effects of heme oxygenase-1 in acute lung injury. Chest. 1999 Jul;116(1 Suppl):61S–63S. doi: 10.1378/chest.116.suppl_1.61s-a. [DOI] [PubMed] [Google Scholar]
  51. Pignatti P. F., Bombieri C., Benetazzo M., Casartelli A., Trabetti E., Gilè L. S., Martinati L. C., Boner A. L., Luisetti M. CFTR gene variant IVS8-5T in disseminated bronchiectasis. Am J Hum Genet. 1996 Apr;58(4):889–892. [PMC free article] [PubMed] [Google Scholar]
  52. Piitulainen E., Eriksson S. Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ). Eur Respir J. 1999 Feb;13(2):247–251. doi: 10.1183/09031936.99.13224799. [DOI] [PubMed] [Google Scholar]
  53. Piitulainen E., Tornling G., Eriksson S. Effect of age and occupational exposure to airway irritants on lung function in non-smoking individuals with alpha 1-antitrypsin deficiency (PiZZ). Thorax. 1997 Mar;52(3):244–248. doi: 10.1136/thx.52.3.244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Piitulainen E., Tornling G., Eriksson S. Environmental correlates of impaired lung function in non-smokers with severe alpha 1-antitrypsin deficiency (PiZZ). Thorax. 1998 Nov;53(11):939–943. doi: 10.1136/thx.53.11.939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Poller W., Faber J. P., Scholz S., Weidinger S., Bartholomé K., Olek K., Eriksson S. Mis-sense mutation of alpha 1-antichymotrypsin gene associated with chronic lung disease. Lancet. 1992 Jun 20;339(8808):1538–1538. doi: 10.1016/0140-6736(92)91301-n. [DOI] [PubMed] [Google Scholar]
  56. Poller W., Meisen C., Olek K. DNA polymorphisms of the alpha 1-antitrypsin gene region in patients with chronic obstructive pulmonary disease. Eur J Clin Invest. 1990 Feb;20(1):1–7. doi: 10.1111/j.1365-2362.1990.tb01769.x. [DOI] [PubMed] [Google Scholar]
  57. Redline S., Tishler P. V., Rosner B., Lewitter F. I., Vandenburgh M., Weiss S. T., Speizer F. E. Genotypic and phenotypic similarities in pulmonary function among family members of adult monozygotic and dizygotic twins. Am J Epidemiol. 1989 Apr;129(4):827–836. doi: 10.1093/oxfordjournals.aje.a115197. [DOI] [PubMed] [Google Scholar]
  58. Retamales I., Elliott W. M., Meshi B., Coxson H. O., Pare P. D., Sciurba F. C., Rogers R. M., Hayashi S., Hogg J. C. Amplification of inflammation in emphysema and its association with latent adenoviral infection. Am J Respir Crit Care Med. 2001 Aug 1;164(3):469–473. doi: 10.1164/ajrccm.164.3.2007149. [DOI] [PubMed] [Google Scholar]
  59. Rybicki B. A., Beaty T. H., Cohen B. H. Major genetic mechanisms in pulmonary function. J Clin Epidemiol. 1990;43(7):667–675. doi: 10.1016/0895-4356(90)90037-p. [DOI] [PubMed] [Google Scholar]
  60. Sakao S., Tatsumi K., Igari H., Shino Y., Shirasawa H., Kuriyama T. Association of tumor necrosis factor alpha gene promoter polymorphism with the presence of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001 Feb;163(2):420–422. doi: 10.1164/ajrccm.163.2.2006031. [DOI] [PubMed] [Google Scholar]
  61. Sandford A. J., Chagani T., Spinelli J. J., Paré P. D. alpha1-antitrypsin genotypes and the acute-phase response to open heart surgery. Am J Respir Crit Care Med. 1999 May;159(5 Pt 1):1624–1628. doi: 10.1164/ajrccm.159.5.9711004. [DOI] [PubMed] [Google Scholar]
  62. Sandford A. J., Chagani T., Weir T. D., Connett J. E., Anthonisen N. R., Paré P. D. Susceptibility genes for rapid decline of lung function in the lung health study. Am J Respir Crit Care Med. 2001 Feb;163(2):469–473. doi: 10.1164/ajrccm.163.2.2006158. [DOI] [PubMed] [Google Scholar]
  63. Sandford A. J., Chagani T., Weir T. D., Paré P. D. Alpha 1-antichymotrypsin mutations in patients with chronic obstructive pulmonary disease. Dis Markers. 1998 Feb;13(4):257–260. doi: 10.1155/1998/867620. [DOI] [PubMed] [Google Scholar]
  64. Sandford A. J., Spinelli J. J., Weir T. D., Paré P. D. Mutation in the 3' region of the alpha-1-antitrypsin gene and chronic obstructive pulmonary disease. J Med Genet. 1997 Oct;34(10):874–875. doi: 10.1136/jmg.34.10.874. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Sandford A. J., Weir T. D., Paré P. D. Genetic risk factors for chronic obstructive pulmonary disease. Eur Respir J. 1997 Jun;10(6):1380–1391. doi: 10.1183/09031936.97.10061380. [DOI] [PubMed] [Google Scholar]
  66. Schellenberg D., Paré P. D., Weir T. D., Spinelli J. J., Walker B. A., Sandford A. J. Vitamin D binding protein variants and the risk of COPD. Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):957–961. doi: 10.1164/ajrccm.157.3.9706106. [DOI] [PubMed] [Google Scholar]
  67. Seersholm N., Kok-Jensen A., Dirksen A. Decline in FEV1 among patients with severe hereditary alpha 1-antitrypsin deficiency type PiZ. Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 1):1922–1925. doi: 10.1164/ajrccm.152.6.8520756. [DOI] [PubMed] [Google Scholar]
  68. Seersholm N., Kok-Jensen A. Survival in relation to lung function and smoking cessation in patients with severe hereditary alpha 1-antitrypsin deficiency. Am J Respir Crit Care Med. 1995 Feb;151(2 Pt 1):369–373. doi: 10.1164/ajrccm.151.2.7842193. [DOI] [PubMed] [Google Scholar]
  69. Seersholm N., Wilcke J. T., Kok-Jensen A., Dirksen A. Risk of hospital admission for obstructive pulmonary disease in alpha(1)-antitrypsin heterozygotes of phenotype PiMZ. Am J Respir Crit Care Med. 2000 Jan;161(1):81–84. doi: 10.1164/ajrccm.161.1.9812131. [DOI] [PubMed] [Google Scholar]
  70. Silverman E. K., Chapman H. A., Drazen J. M., Weiss S. T., Rosner B., Campbell E. J., O'DONNELL W. J., Reilly J. J., Ginns L., Mentzer S. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. Am J Respir Crit Care Med. 1998 Jun;157(6 Pt 1):1770–1778. doi: 10.1164/ajrccm.157.6.9706014. [DOI] [PubMed] [Google Scholar]
  71. Silverman E. K., Pierce J. A., Province M. A., Rao D. C., Campbell E. J. Variability of pulmonary function in alpha-1-antitrypsin deficiency: clinical correlates. Ann Intern Med. 1989 Dec 15;111(12):982–991. doi: 10.7326/0003-4819-111-12-982. [DOI] [PubMed] [Google Scholar]
  72. Silverman E. K., Speizer F. E. Risk factors for the development of chronic obstructive pulmonary disease. Med Clin North Am. 1996 May;80(3):501–522. doi: 10.1016/s0025-7125(05)70451-x. [DOI] [PubMed] [Google Scholar]
  73. Silverman Edwin K., Mosley Jonathan D., Palmer Lyle J., Barth Matthew, Senter Jody M., Brown Alison, Drazen Jeffrey M., Kwiatkowski David J., Chapman Harold A., Campbell Edward J. Genome-wide linkage analysis of severe, early-onset chronic obstructive pulmonary disease: airflow obstruction and chronic bronchitis phenotypes. Hum Mol Genet. 2002 Mar 15;11(6):623–632. doi: 10.1093/hmg/11.6.623. [DOI] [PubMed] [Google Scholar]
  74. Silverman Edwin K., Palmer Lyle J., Mosley Jonathan D., Barth Matthew, Senter Jody M., Brown Alison, Drazen Jeffrey M., Kwiatkowski David J., Chapman Harold A., Campbell Edward J. Genomewide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease. Am J Hum Genet. 2002 Mar 25;70(5):1229–1239. doi: 10.1086/340316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Smith C. A., Harrison D. J. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet. 1997 Aug 30;350(9078):630–633. doi: 10.1016/S0140-6736(96)08061-0. [DOI] [PubMed] [Google Scholar]
  76. Sugiyama Y., Kudoh S., Maeda H., Suzaki H., Takaku F. Analysis of HLA antigens in patients with diffuse panbronchiolitis. Am Rev Respir Dis. 1990 Jun;141(6):1459–1462. doi: 10.1164/ajrccm/141.6.1459. [DOI] [PubMed] [Google Scholar]
  77. Sundberg K., Johansson A. S., Stenberg G., Widersten M., Seidel A., Mannervik B., Jernström B. Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis. 1998 Mar;19(3):433–436. doi: 10.1093/carcin/19.3.433. [DOI] [PubMed] [Google Scholar]
  78. Tager I., Tishler P. V., Rosner B., Speizer F. E., Litt M. Studies of the familial aggregation of chronic bronchitis and obstructive airways disease. Int J Epidemiol. 1978 Mar;7(1):55–62. doi: 10.1093/ije/7.1.55. [DOI] [PubMed] [Google Scholar]
  79. Tobin M. J., Cook P. J., Hutchison D. C. Alpha 1 antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z. A survey by the British Thoracic Association. Br J Dis Chest. 1983 Jan;77(1):14–27. doi: 10.1016/0007-0971(83)90002-5. [DOI] [PubMed] [Google Scholar]
  80. Turino G. M., Barker A. F., Brantly M. L., Cohen A. B., Connelly R. P., Crystal R. G., Eden E., Schluchter M. D., Stoller J. K. Clinical features of individuals with PI*SZ phenotype of alpha 1-antitrypsin deficiency. alpha 1-Antitrypsin Deficiency Registry Study Group. Am J Respir Crit Care Med. 1996 Dec;154(6 Pt 1):1718–1725. doi: 10.1164/ajrccm.154.6.8970361. [DOI] [PubMed] [Google Scholar]
  81. Tzetis M., Efthymiadou A., Strofalis S., Psychou P., Dimakou A., Pouliou E., Doudounakis S., Kanavakis E. CFTR gene mutations--including three novel nucleotide substitutions--and haplotype background in patients with asthma, disseminated bronchiectasis and chronic obstructive pulmonary disease. Hum Genet. 2001 Mar;108(3):216–221. doi: 10.1007/s004390100467. [DOI] [PubMed] [Google Scholar]
  82. Umbach D. M. Invited commentary: on studying the joint effects of candidate genes and exposures. Am J Epidemiol. 2000 Oct 15;152(8):701–703. doi: 10.1093/aje/152.8.701. [DOI] [PubMed] [Google Scholar]
  83. Webb D. R., Condemi J. J. Selective immunoglobulin A deficiency and chronic obstructive lung disease. A family study. Ann Intern Med. 1974 May;80(5):618–621. doi: 10.7326/0003-4819-80-5-618. [DOI] [PubMed] [Google Scholar]
  84. Wilk J. B., Djousse L., Arnett D. K., Rich S. S., Province M. A., Hunt S. C., Crapo R. O., Higgins M., Myers R. H. Evidence for major genes influencing pulmonary function in the NHLBI family heart study. Genet Epidemiol. 2000 Jul;19(1):81–94. doi: 10.1002/1098-2272(200007)19:1<81::AID-GEPI6>3.0.CO;2-8. [DOI] [PubMed] [Google Scholar]
  85. Yamada N., Yamaya M., Okinaga S., Nakayama K., Sekizawa K., Shibahara S., Sasaki H. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet. 2000 Jan;66(1):187–195. doi: 10.1086/302729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Yim J. J., Park G. Y., Lee C. T., Kim Y. W., Han S. K., Shim Y. S., Yoo C. G. Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1. Thorax. 2000 Feb;55(2):121–125. doi: 10.1136/thorax.55.2.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Yoshikawa M., Hiyama K., Ishioka S., Maeda H., Maeda A., Yamakido M. Microsomal epoxide hydrolase genotypes and chronic obstructive pulmonary disease in Japanese. Int J Mol Med. 2000 Jan;5(1):49–53. doi: 10.3892/ijmm.5.1.49. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES